Herpesvirus pathogenesis is closely linked to host immune status. The majority of herpesvirusinfected individuals never experience clinical symptoms, but infection among the immunocompromised is a risk factor for numerous complications ( 1 ) . MHV68 is a ␥ 2 herpesvirus, closely related to the human pathogens EBV and Kaposi ' s sarcoma -associated herpesvirus ( 2, 3 ) . Like human herpesviruses, the vast majority of MHV68-infected immunocompetent mice do not develop disease; however, chronic infection of IFN ␥ R Ϫ / Ϫ mice is a notable exception ( 4 -6 ) . IFN ␥ directly inhibits viral replication and/or reactivation from latency in specifi c cell types, i.e., macrophages but not B cells ( 7, 8 ) . In the absence of an IFN ␥ response in vivo, persistent MHV68 replication emerges several weeks after infection and promotes a lethal infl ammatory disorder consisting of lymphocytic infi ltrates in multiple organs and fi brotic changes in the spleen, lymph nodes, and lung ( 6, 9 ) . The resulting pulmonary disease is studied as a model for human idiopathic pulmonary fi brosis (IPF) associated with gammaherpesvirus infection ( 10 -12 ) , and persistent virus replication in the great elastic arteries gives rise to lesions that bear resemblance to clinical vasculitides such as Takayasu ' s arteritis and Kawasaki disease ( 13 -15 ) . Although the precise etiology of organ fi brosis is unknown, and probably wide ranging in both humans and animals models, three distinct elements are essential in the pathogenesis of MHV68-induced fi brotic disease: (a) persistent viral replication; (b) host T cells; and (c) a unique viral gene of unknown function, designated M1 ( 6, 11, 15, 16 ) .
The M1 gene of MHV68 suppresses reactivation from latency in immunocompetent C57BL/6 mice, but the mechanism by which it exerts this eff ect, and the extent of immune system involvement, is unknown ( 16 ) . The M1 gene is unique to MHV68 and is encoded within a locus of multiple unique open reading frames (ORFs). are potentially ground-breaking because they identify a secreted viral protein that stimulates murine CD8 + T cells in an apparently novel fashion and demonstrate that such activity either contributes to immunological control of infection or virus-induced disease, depending on the status of the host ' s immune system.
RESULTS

MHV68 immunopathology induced by the M1 ORF is associated with the presence of V ␤ 4 + CD8 + T cells
We previously demonstrated that IFN ␥ R Ϫ / Ϫ mice infected with an M1-defi cient virus do not exhibit the mortality or fi brotic changes associated with WT MHV68 infection ( 16 ) . It was independently shown that both CD8 + and CD4 + T cells were required for splenic fi brosis during MHV68 infection ( 6 ) . Therefore, we compared the T cell response elicited by WT and M1 mutant MHV68 infection in IFN ␥ R Ϫ / Ϫ mice. We extended the initial observation (which used a mutant containing a large insertion into the M1 ORF) using a mutant virus with a targeted 511-bp deletion (M1 ⌬ 511) spanning the 5 Ј end of M1 ORF ( 16 ) . In agreement with previously published data ( 16 ) , the spleens of M1 ⌬ 511-infected mice exhibited a normal histological appearance as compared with M1 marker rescue (M1.MR) control virus, which promoted extensive fi brotic scarring and decreased cellularity in infected spleens by 1 mo after infection ( Fig. 1 A ) . Beyond the spleen, M1.MR virus induced extensive lymphocytic infi ltrates throughout the lung and liver, whereas M1 ⌬ 511 virus did not produce any signs of disease ( Fig. 1 A ) .
When the T cell response for each group of mice was examined at the same time point, the absence of infl ammatory changes in M1 ⌬ 511-infected animals correlated with the absence of an activated CD8 + T cell population (CD11a hi , CD44 + , and CD62L lo ; unpublished data). Surprisingly, the lack of activated T cells in M1 ⌬ 511-infected mice could be attributed to a total defi ciency of V ␤ 4 + CD8 + T cell expansion ( Fig. 1 B ) . A direct association between V ␤ 4 + CD8 + T cell activation and disease was suggested by immunohistochemical staining of the pulmonary infi ltrates from M1.MR-infected mice, demonstrating that the infl ammatory lesions contained substantial numbers of V ␤ 4 + and CD8 + T cells ( Fig. 1 C ) . Importantly, the titer of persistently replicating virus in the diseased organs of M1.MR-infected mice was comparable to the titer in the healthy tissues from M1 ⌬ 511-infected mice ( Fig.  1 D ) . In agreement with the absence of pulmonary infl ammation at 28 d after infection, long-term fi brotic changes were not detected in the lungs of M1 ⌬ 511-infected mice as late as 180 d after infection as compared with those infected with WT MHV68 ( Fig. 1 E ) . Thus, the failure of M1 ⌬ 511 to induce chronic T cell -mediated fi brosis correlated with the absence of V ␤ 4 + CD8 + T cell activation and corresponding infl ammation, strongly suggesting that these T cells play a critical role in the pathogenesis of fi brotic disease in IFN ␥ R Ϫ / Ϫ mice. These data also demonstrate that persistent virus replication is insufficient to cause fi brotic disease in the absence of M1 expression and the associated V ␤ 4 + CD8 + T cell response.
Each ORF is dispensable for in vitro growth, but critical for regulating aspects of in vivo infection ( 16 -23 ) . Based on the capacity of M1 to inhibit reactivation in vivo, it was unexpected that M1 also promotes fi brotic disease in IFN ␥ R Ϫ / Ϫ mice -a T cell -mediated process that was previously thought to result directly from persistent virus replication ( 11, 16 ) .
Antiviral CD8 + T cell responses help control both lytic and latent MHV68 infection ( 24 -28 ) . Eventually, antigenspecifi c T cell responses become down-regulated, exhibit little evidence of continued activation, and contract in the manner typical of memory T cell responses. ( 29 -31 ) . A notable exception to this pattern is the V ␤ 4 + CD8 + T cell response. In the third week after infection, cells bearing a V ␤ 4 + TCR rapidly proliferate, rise to the level of 30 -60% of peripheral CD8 + T cells in C57BL/6 mice, and remain at elevated levels throughout the course of latency ( 32, 33 ) . The V ␤ 4 + CD8 + T cell response has been proposed as a mouse model for EBV-induced infectious mononucleosis (IM), but the degree of similarity between the two phenomena is ill-defi ned ( 34, 35 ) . A latency-specifi c stimulus for the V ␤ 4 + response is suggested because latency-defi cient MHV68 mutants fail to generate a response during lytic infection and because B cells (the major latency reservoir for MHV68) are required for V ␤ 4 + CD8 + T cell expansion ( 30, 36 -38 ) . This response is not limited to C57BL/6 mice, but occurs to varying degrees in a wide variety of inbred mice, demonstrating preferential expansion among strains expressing the H2 b MHC haplotype ( 32, 39 ) . Superantigen-driven proliferation was proposed for this response because it is confi ned to cells expressing a single variable region in the TCR ␤ chain and it is not defi nitively MHC restricted ( 32 ) . However, V ␤ 4 + CD8 + T cell expansion is not broadly polyclonal (based on complementarity-determining region -3 size analysis and V-D-J junctional region diversity) as demonstrated for classical CD4 + superantigen responses ( 40 ) . Numerous lines of evidence have shown that V ␤ 4 + CD8 + T cell activation does not require classical MHC class Ia antigen presentation, including studies of mice defi cient for MHC class Ia molecules
, and the transporter associated with antigen processing (TAP Ϫ / Ϫ ) ( 37, 41 ) . These data either implicate a role for ␤ 2m-independent, nonpolymorphic MHC class Ib molecules or an unconventional, MHC-independent mechanism of CD8 + T cell activation. Ultimately, the identity of the V ␤ 4 + CD8 + T cell stimulatory ligand and its biological signifi cance has remained elusive.
The goal of this study was to investigate a potential immunomodulatory function for the MHV68 M1 gene product that could explain its role in regulating virus reactivation and disease. This fi rst led to the surprising fi nding that the M1-dependent immunopathology observed in MHV68-infected IFN ␥ R Ϫ / Ϫ mice is associated with activation of the enigmatic V ␤ 4 + CD8 + T cell population and second to the discovery that the M1 antigen of MHV68 is capable of stimulating V ␤ 4 + CD8 + T cells both in vivo and in vitro in a manner consistent with superantigen-like behavior. These data sisting of three recombinant viruses harboring translation stop codons within each of the M1 neighboring genes (M2, M3, and M4), as well as a large-scale deletion mutant ( ⌬ 9473) that spans nearly 9.5 kb and encompasses the entire left end of the genome, including M1 ( Fig. 2 C ) ( 17 -19, 22 ) . After infection of immunocompetent C57BL/6 mice with each virus, the extent of V ␤ 4 + CD8 + T cell expansion was assessed at the normal peak of this response at 28 d after infection. Only the M1 ⌬ 511 virus and the ⌬ 9473 virus failed to induce V ␤ 4 + CD8 + T cell expansion, whereas the extent of V ␤ 4 + CD8 + T cell expansion was comparable among all other viral mutants tested ( Fig. 2, A and B ) . Importantly, the M1 ⌬ 511 mutant both replicates and establishes latency in vivo at levels comparable to WT virus; thus, the failure of the M1 mutant virus The M1 ORF is required for V ␤ 4 + CD8 + T cell expansion The V ␤ 4 + CD8 + T cell response is a highly unusual example of an antiviral T cell response because of its activation profi le, kinetics, and apparent MHC independence ( 32, 33, 37, 39, 41 ) . The hypothesis that V ␤ 4 + CD8 + T cell activation is the result of a viral superantigen was proposed, but a candidate T cell ligand has never been identifi ed ( 32 ) . Having demonstrated that loss of M1 ablates this response, we considered that M1 might be the putative viral T cell stimulatory ligand. To focus on M1 and rule out other viral factors, we set about a more rigorous genetic mapping of adjacent mutations in the MHV68 genome that might aff ect V ␤ 4 + T cell activation. In addition to the aforementioned M1 ⌬ 511 mutant and control virus, a panel of individual viral mutants was compiled con- failure of previous M1-defi cient viruses to induce V ␤ 4 + CD8 + T cell expansion during latency ( Fig. 2, A and B ) . Likewise, M1.STOP infection failed to induce spleen, lung, or liver infl ammatory lesions in infected IFN ␥ R Ϫ / Ϫ mice, as shown for M1 ⌬ 511 virus in Fig. 1 (not depicted) . Thus, we concluded that the MHV68 M1 gene product is critical in promoting the expansion and activation of the V ␤ 4 + CD8 + T cell population.
Control of virus reactivation is dependent on the M1 ORF and V ␤ 4 + CD8 + T cell expansion Disruption of the M1 ORF results in enhanced reactivation from latency in peritoneal exudate cells (PECs) recovered from infected C57BL/6 mice, and thus the M1-encoded gene product was proposed to act as an inhibitor of virus reactivation ( 16 ) . Indeed, both M1.STOP and M1 ⌬ 511 mutants exhibit roughly a 10-fold higher frequency of reactivation from PECs at 6 wk after infection as compared with M1.MR and WT MHV68, whereas the frequency of infected cells was the same for each ( Fig. 3 B ) . We postulated that the capacity of M1 to suppress reactivation resulted from large-scale V ␤ 4 + T cell activation and their acquisition of antiviral eff ector functions.
to induce V ␤ 4 + CD8 + T cell expansion was not caused by an attenuated viral infection, as has been shown with other latency-defi cient mutants ( 21, 30 ) . In addition, the absence of V ␤ 4 + CD8 + T cell expansion after M1 ⌬ 511 infection was not the result of delayed kinetics of T cell activation because both M1 ⌬ 511 and ⌬ 9473 viruses did not exhibit any evidence of V ␤ 4 + T cell expansion at 42 d, 3 mo, and 1 yr after infection, whereas WT and M1.MR virus demonstrated the characteristic protracted response ( Fig. 2 B ) . Finally, in the absence of a V ␤ 4 + CD8 + T cell response during M1 ⌬ 511 infection, no other V ␤ subset was seen to expand in compensation ( Fig. 2 D ) .
Because the region immediately adjacent to the M1 gene contains several viral tRNA-like and putative miRNA genes ( 42 -44 ) , it was possible that the 511-bp deletion spanning the 5 Ј end of the M1 gene might also impact expression of one or more of these genes ( Fig. 1 C ) . Thus, to more defi nitively determine whether the V ␤ 4 + CD8 + T cell expansion and activation maps to the M1 ORF, we engineered a new MHV68 M1 mutant, M1.STOP, by altering 6 bp at the 5 Ј end of the M1 ORF to introduce two translation stop codons and a frameshift mutation ( Fig. 2 C ) . Notably, infection of C57BL/6 mice with the M1.STOP mutant virus fully recapitulated the To further investigate the association between M1 control of virus reactivation and activation of V ␤ 4 + CD8 + T cells, we took advantage of intrinsic genetic diff erences between inbred strains of mice. This approach was necessary because attempts to eliminate V ␤ 4 + T cells via antibody depletion proved unsuccessful (see Discussion). The extent of MHV68-driven V ␤ 4 + CD8 + T cell expansion varies widely between mouse strains in accordance with their MHC haplotype. Specifi cally, mice bearing an H-2 b MHC haplotype (e.g., C57BL/6) show a greater V ␤ 4 + CD8 + T cell expansion than animals expressing H-2 d haplotypes ( 39 ) . Thus, we reasoned that the lack of a robust V ␤ 4 + CD8 + T cell response in mice with an H-2 d haplotype would minimize the capacity of M1 to infl uence reactivation from latency. To test this hypothesis, BALB/c mice (H-2 d ) were infected with M1. STOP and WT virus, and the impact of M1 on virus reactivation and V ␤ 4 + CD8 + T cell expansion was examined. WT MHV68 infection of BALB/c mice resulted in a modest, approximately twofold expansion of the V ␤ 4 + CD8 + T cell population in the first month after infection, which was no longer evident by 1 yr after infection ( Fig. 4 , A and B ). Notably, this small expansion was also observed with M1.MR virus, but not upon infection with the M1 ⌬ 511 mutant ( Fig. 4 A ) . Next, BALB/c mice were infected via intraperitoneal inoculation and PEC reactivation was examined at 6 wk after infection. As predicted, the frequency of reactivation from latently infected PECs did not diff er signifi cantly between M1.STOP and WT virus-infected mice ( Fig. 4 C ) . Thus, we concluded that M1 is incapable of infl uencing virus reactivation in mice that are intrinsically unable to mount a robust Notably, neither M1-dependent reactivation nor V ␤ 4 + CD8 + T cell expansion was infl uenced by viral dose (Fig. S1 , available at http://www.jem.org/cgi/content/full/jem.20071135/DC1). To assess whether the control of reactivation and the stimulation of CD8 + T cells are functionally linked, reactivation of M1-null viruses was examined under conditions in which the V ␤ 4 + CD8 + T cell expansion and activation are not apparent. First, reactivation from latency was measured for each virus before the expansion of V ␤ 4 + CD8 + T cells. We confi rmed that V ␤ 4 + CD8 + T cell expansion begins 18 -20 d after infection and that the response does not vary by route of infection (unpublished data). Mice were examined at 16 -18 d after intraperitoneal inoculation, and the frequencies of reactivating PECs did not signifi cantly diff er between M1.STOP, M1 ⌬ 511, M1.MR, or WT viruses ( Fig. 3 A ) . Thus, M1-dependent control of reactivation can only be detected after the expansion of the V ␤ 4 + CD8 + T cell population. A model for control of reactivation by V ␤ 4 + CD8 + T cells implies that their persistent state of activation should predict longterm viral control that is dependent on M1. Accordingly, the frequency of PECs reactivating virus at 195 -220 d after infection from M1 ⌬ 511-infected mice was > 10-fold higher than observed with the M1.MR-infected mice, whereas the frequency of viral genome-positive cells was only slightly skewed in favor of the mutant ( Fig. 3 C ) . This relatively small increase in viral load cannot account for the greatly elevated reactivation seen with M1 ⌬ 511. Thus, the kinetics of V ␤ 4 + CD8 + T cell expansion correlates well with the time course over which M1 represses reactivation from latently infected PECs. . The relative contribution of preformed infectious virus was evaluated in parallel by mechanically disrupting the maximum number of cells and plating the cell lysates in parallel. In each of the experiments, the contribution of preformed virus accounted for ≤ 1% of the CPE produced by plating intact cells (not depicted). The frequency of latently infected, viral genome-positive cells was measured by subjecting a limiting dilution series of cells to lysis and proteinase K digestion, followed by highly sensitive nested PCR capable of detecting a single copy of the MHV68 genome (bottom). Graphs represent the combined data from three independent experiments with 4 -5 animals per group. Error bars denote the SD.
V ␤ 4 + CD8 + T cell response. Collectively, the data showing identical kinetics of V ␤ 4 + T cell expansion and M1-dependent reactivation in C57BL/6 mice and the absence of an M1-associated reactivation phenotype in mice that lack robust expansion of V ␤ 4 + CD8 + T cells, argue that the M1-dependent control of virus reactivation from latently infected PECs functions through an activated V ␤ 4 + CD8 + T cell mediator.
V ␤ 4 + CD8 + T cells exhibit an effector memory phenotype without signs of functional exhaustion The capacity of V ␤ 4 + CD8 + T cells to regulate chronic viral reactivation implies that these cells are potent antiviral eff ector cells. At the peak of the V ␤ 4 + CD8 + T cell response within the spleen, these cells are CD11a (LFA-1) hi , CD44 + , CD62L (L-selection) lo , and CD127 (IL-7R ␣ ) lo ( Fig. 5 A ) , although negative for CD25 and CD69 expression as previously reported (not depicted) ( 33 ) . Each feature is maintained as late as 6 mo after infection, with the exception of CD127, which was up-regulated by this time ( Fig. 4 A and unpublished data), indicating that the persistence of the V ␤ 4 + CD8 + T cell response was analogous to the maintenance of an eff ector memory T cell population ( 45 ) . The V ␤ 4 + population also expresses the C-type lectin inhibitory receptor NKG2A, which is often found on NK and activated CD8 + T cells ( Fig. 5 A ) ( 46 ) . In contrast, V ␤ 4 + CD8 + T cells did not express the PD-1 inhibitory receptor at any time between 28 d to 6 mo after infection, as is characteristic of activated and/ or chronically exhausted CD8 + T cells ( Fig. 5 A and not depicted) ( 47 ) .
Ongoing proliferation among the expanded V ␤ 4 + CD8 + T cell population appears to be on par with the rate of homeostatic proliferation among all other CD8 + T cells in infected mice, as determined by in vivo BrdU incorporation over a 1-wk course of treatment during the fourth month after infection ( Fig. 5 A ) . Cytokine production was measured as an indicator of T cell function by ex vivo stimulation with anti-CD3, and revealed potent production of both IFN ␥ and TNF-␣ by V ␤ 4 + CD8 + T cells from 28 d to 6 mo after infection ( Figs. 5, A and B, and Fig. 6, C -E ) . Notably, in the absence of M1 expression and V ␤ 4 + CD8 + T cell expansion, the proportion of CD8 + T cells capable of eliciting IFN ␥ upon ex vivo stimulation was drastically reduced ( Fig. 5 B and Fig. S2 , available at http://www.jem.org/cgi/content/full/jem.20071135/DC1). Thus, the V ␤ 4 + CD8 + T cell response that resists functional exhaustion likely represents a key source of IFN ␥ production for the regulation of viral reactivation.
M1 encodes a secreted protein capable of stimulating V ␤ 4 + CD8 + T cells specifi cally
To assess the possibility that the M1 gene product directly stimulates CD8 + T cells in a manner analogous to a superantigen, mice 4 -6 mo after WT MHV68 infection (diagrammed in Fig. 6 B ) . Stimulation of V ␤ 4 + CD8 + T cells was measured using intracellular cytokine (ICC) staining for IFN ␥ production. Anti-CD3 antibody was used as a nonspecifi c TCR cross-linking agonist to assess the total capacity for IFN ␥ production, and elicited robust cytokine levels from V ␤ 4 + CD8 + T cells at all times tested ( Fig. 6 C ) . In cultures containing the M1 antigen as a stimulus, a substantial portion (10 -20%) of V ␤ 4 + CD8 + T cells also produced IFN ␥ , whereas no activation was elicited by recombinant M3 protein ( Fig. 6 C ) . Importantly, M1-mediated T cell stimulation was lost when recombinant M1 protein was depleted from the supernatant by anti-FLAG immunoprecipitation, indicating that stimulation was specifi c to the presence of the M1 antigen and not a secondary eff ect of another soluble factor elicited by M1 expression ( Fig. 7 A ) . Notably, even in the absence of in vitro stimulation, intracellular IFN ␥ could often be detected within the V ␤ 4 + CD8 + T cells from certain infected mice, demonstrating the likelihood that V ␤ 4 + CD8 + T cells contribute to persistent IFN ␥ production in vivo ( Fig. 6 C ) . In contrast to the behavior of the activated V ␤ 4 + CD8 + T cell population recovered from WT MHV68-infected mice, recombinant M1 antigen was not capable of stimulating IFN ␥ production from unexpanded V ␤ 4 + CD8 + T cells derived from the spleen of M1.STOP-infected or naive mice in the ICC assay (Fig. S2) . The incapacity of M1 to rapidly induce IFN ␥ production as originally speculated for the V ␤ 4 + stimulatory ligand ( 32 ), we generated recombinant protein and tested its capacity to activate primary T cells. The putative M1 antigen is predicted to be a 47-kD secreted protein, based on the presence of a 19-aa, N-terminal consensus secretory signal peptide. Notably, both the neighboring M3 and M4 genes of MHV68 encode secreted proteins, and the low level homology shared between M1, M3, and M4 ORFs, suggests all three likely arose through gene duplication events ( 18, 48 ) . To determine if the M1 antigen is truly a secreted protein with the potential to directly interact with V ␤ 4 + CD8 + T cells, we cloned the full-length M1 ORF (with a C-terminal FLAG-epitope tag) into a eukaryotic expression vector and expressed M1 by transient transfection into Cos-1 cells. As predicted, an ‫ف‬ 47-kD protein was detected in the transfected culture supernatant after anti-FLAG immunoprecipitation ( Fig. 6 A ) . Expression of a FLAG-tagged version of the MHV68 M3 chemokinebinding protein served as a positive control for secretory transport, whereas a FLAG-tagged MHV68 v-cyclin expression vector resulted in protein expression that was detected only within the whole-cell lysate ( Fig. 6 A ) .
To determine if secreted M1 antigen could directly stimulate V ␤ 4 + CD8 + T cells in vitro, cell-free supernatants recovered from Cos-1 cells transfected with either the M1 expression vector, or control expression vectors (M3 and v-cyclin), were used to stimulate splenocytes recovered from infection (lacking an expanded V ␤ 4 + population) were compared in parallel with those from mice 2 mo after infection. In side-by-side experiments M1 was devoid of any stimulatory activity among the day 12 eff ector CD8 + T cells, which were capable of responding to anti-CD3 treatment, but produced signifi cant up-regulation of IFN ␥ among the V ␤ 4 + population from latently infected tissues ( Fig. 6 D ) . The same pattern was true of cells from the peritoneal compartment. Recombinant M1 had no infl uence on eff ector CD8 + T cells present during lytic infection (unpublished data), but exhibited robust activity among V ␤ 4 + cells taken at 2 mo after infection ( Fig. 6 E ) . Importantly, peritoneal cells from latently infected mice off ered a comparison of activity among V ␤ 4 + and V ␤ 4 Ϫ T cells, which are both capable of expressing IFN ␥ within the same sample, and, as such, demonstrated that the infl uence of M1 was absolutely restricted to the V ␤ 4 + population ( Fig. 6 E ) . Thus, under these conditions, M1 is incapable of stimulating conventional CD8 + eff ector T cells generated during lytic infection, and shows specifi city for the presence of a V ␤ 4 + TCR upon ex vivo stimulation. The inability of M1 to infl uence conventional CD8 + T cell responses is further supported by data demonstrating that the peak size of an antigen-specifi c (tetramer-positive) CD8 + T cell response to MHV68 does not signifi cantly diff er between infection with M1.STOP and WT virus (Fig. S3 , available at http://www .jem.org/cgi/content/full/jem.20071135/DC1).
V ␤ 4 + TCR activation by M1 requires a functional protein and is independent of professional antigen presentation
To assess the requirement for functional M1-mediated protein interactions during T cell stimulation, we disrupted native M1 protein structure via either heat denaturation or enzymatic cleavage with thrombin protease (a single predicted thrombin recognition site exists midway through the protein). The loss of T cell stimulation under either condition suggested M1 activity was dependent on properly folded, intact recombinant protein ( Fig. 7 A ) . Furthermore, it indicated that the stimulatory activity is unlikely to result from an M1-derived peptide epitope presented in an MHC-dependent context during the ICC assay. Such a conclusion was also supported by the inability of a proteasome inhibitor (18 μ M lactacystin) to diminish V ␤ 4 + CD8 + T cell activation mediated by recombinant M1 (unpublished data). From these analyses, we conclude that the intact extracellular M1 antigen is required to induce V ␤ 4-specifi c T cell stimulation after MHV68 infection, implicating a mechanism for V ␤ -specifi c TCR engagement in a manner similar to known superantigens.
Second, we examined the capacity of M1 to stimulate MHV68-specifi c V ␤ 4 + CD8 + T cell hybridomas. The hybridoma lines respond to MHV68-infected splenocytes even in the presence of MHC class I and II blocking antibodies or M1-containing supernatants were modifi ed in the following manner. Depleted and nondepleted supernatants were immunoprecipitated using anti-FLAG-and IgG-conjugated agarose, respectively. Thrombin-conjugated agarose was used to protease digest recombinant M1, and then enzyme was removed by precipitation and inactivated with protease inhibitors. M1 contains a single predicted thrombin cleavage domain approximately midway through the primary sequence. M1 denaturation was the result of a 10-min incubation at 94 ° C. Asterisks indicate signifi cantly different values for representative columns (P < 0.05). (B) V ␤ 4 + CD8 + hybridoma (4BH62) was cultured in isolation from any other cells for 36 h in the presence of M1-and M3-containing supernatants or conditioned supernatants from Cos-1 cells both with and without 1 μ g/ml anti-CD3. Cells were fi xed, stained with X-gal for LacZ expression, and photographed under an inverted microscope. Bars, 80 μ m. (C) ELISA measurements for the concentration of IL-2 in the culture supernatant of each hybridoma line after 36 h stimulation under the indicated conditions, as in part B. The limit of detection is 2 pg/ml. As a control, all supernatants were tested and found below the limit of detection before being used to culture hybridoma lines (not depicted). Error bars denote the SD.
antigen is necessary for the V ␤ 4 + CD8 + T cell response to occur in vivo and is suffi cient to induce V ␤ 4 + TCR signaling in vitro, conclusively demonstrating that M1 is the viral determinant responsible for this immune reaction. M1 activity has several features in common with superantigen-mediated T cell activation, including the following: (a) that it occurs to varying degrees in multiple MHC backgrounds, (b) is independent of professional antigen presentation, and (c) is the result of functional protein -protein interactions that occur specifi cally with cells bearing a V ␤ 4 + TCR. The consequences of the superantigen-like response determine several features of MHV68 infection. Upon activation, V ␤ 4 + CD8 + T cells from C57BL/6 mice appear to suppress reactivation from some populations of latently infected cells, which correlates with the capacity to express high levels of IFN ␥ , a known inhibitor of MHV68 reactivation from macrophages ( Fig. 8 ) ( 7, 8 ) . Furthermore, in animals unable to regulate reactivation via IFN ␥ signaling (IFN ␥ R Ϫ / Ϫ ), the presence of the activated V ␤ 4 + CD8 + T cell population is associated with severe infl ammation and fi brotic scarring of multiple tissues ( Fig. 8 ) .
Mechanism of M1 action
Identifi cation of a viral molecule that stimulates CD8 + T cells in a manner reminiscent of a superantigen is a novel discovery in regard to both microbial pathogenesis and T cell receptor signaling. Superantigens are expressed by other viruses, including the mouse mammary tumor virus, mls antigen, and Rabies virus nucleocapsid; superantigen activity is implicated in EBV, human cytomegalovirus (HCMV), and herpesvirus saimiri infection ( 49 -54 ) . Like their bacteriological counterparts, when infected splenocytes lacking MHC class I expression ( ␤ 2-microglobulin Ϫ / Ϫ ) are used ( 37 ) . Each hybridoma line (4BH62 and 4BH98) expresses a distinct V ␤ 4 + TCR of different complementarity-determining region -3 length and contains a ␤ -galactosidase ( LacZ ) reporter gene regulated by the nuclear factor of activated T cells (NF-AT). After 36 h of stimulation in the presence of M1-containing supernatant, a signifi cant number of the V ␤ 4 + CD8 + T cell hybridoma cells expressed detectable LacZ expression ( Fig. 7 B ) . The number of responding cells was on par with the proportion expressing LacZ after anti-CD3 stimulation, whereas no cells were seen to respond to either M3 or mock treatment ( Fig. 7 B ) . Next, interleukin-2 (IL-2) secretion was measured under each condition. A non-V ␤ 4 CD8 + T cell hybridoma (LT359) derived from a polyoma virus-specifi c T cell response was used as a control for V ␤ -specifi city. IL-2 production for each V ␤ 4 + hybridoma was similar, if not greater, after treatment with M1 as compared with anti-CD3, whereas background levels of IL-2 were undetectable ( Fig. 7 C ) . Notably, the polyomaspecifi c V ␤ 4 Ϫ hybridoma demonstrated robust IL-2 production in response to anti-CD3 stimulation, but not in response to treatment with M1 ( Fig. 7 C ) . Thus, M1 has the capacity to induce signaling through multiple TCR clones in a V ␤ 4-specifi c manner in the absence of professional antigen-presenting cells or any other viral gene product.
DISCUSSION
The salient features of the V ␤ 4 + CD8 + T cell response have been interpreted as evidence for an unconventional viral superantigen, although no such molecule has previously been identifi ed. Our results demonstrate that the MHV68 M1 Fig. 1 D . but the in vivo relevance of this activity is not known ( 33 ) . The same study reported V ␤ 4 + T cell depletion has no signifi cant impact on viral genome load or reactivation from splenocytes, specifi cally; this is a conclusion that is consistent with our own. It should be noted, however, that our attempt to perform a similar depletion protocol using the same monoclonal antibody (KT4, the only V ␤ 4-specifi c monoclonal antibody available to our knowledge) was unsuccessful. Treatment rendered the V ␤ 4 + population undetectable by fl ow cytometry with the same monoclonal antibody, but no change in IFN ␥ production was evident in anti-V ␤ 4 -treated versus isotype-control -treated mice (Fig. S4 , available at http://www .jem.org/cgi/content/full/jem.20071135/DC1). These data argue that use of the KT4 antibody masks detection with the same monoclonal species, but does not eff ectively deplete the V ␤ 4 + CD8 + T cell population during MHV68 infection. Thus, analyses with an M1 mutant virus may be the most reliable method for evaluating the functional consequences of this T cell response.
The capacity of V ␤ 4 + CD8 + T cells to maintain functionality over a period of months, and perhaps years, in spite of their continual activation, is in apparent contrast to many antigen-specifi c T cell responses in other well-known persistent viral infections. Chronic lymphocytic choriomeningitis virus, hepatitis C virus, and simian and human immunodefi ciency virus infections eventually result in the development of CD8 + T cell responses with " exhausted " characteristics, including poor proliferative potential, limited eff ector cytokine production (i.e., TNF-␣ ), and reduced cytolytic activity. This phenomenon, which is thought to result from chronic exposure to viral antigen, is mediated by the PD-1 surface receptor and contributes to the failure to control viral infection in certain cases ( 63 ) . V ␤ 4 + CD8 + T cells exhibit the opposite profi le, as they fail to express PD-1 on their surface, maintain production of eff ector cytokines, and exhibit long-term control of persistent virus reactivation. Such a comparison implies that either a relatively low level of activity is required for V ␤ 4 + CD8 + T cells to control reactivation (i.e., no cytolytic activity and limited cytokine production), or that their activation state is distinct from classical antiviral responses. T cell responses to other latent herpesviruses (i.e., EBV and human or mouse cytomegalovirus) have been described which do not exhibit the hallmarks of exhaustion, but during latency the extent of conventional antigen exposure is presumably low. The paradox of the V ␤ 4 + CD8 + T cell response to MHV68 is how such a large and activated CD8 + T cell response maintains its size, status, and functional activity. Understanding the mechanisms by which M1 induces persistent V ␤ 4 + CD8 + T cell activation may provide insight into TCR signaling mechanisms by which more durable and eff ective T cell responses can be generated against chronic viruses.
Latency as a requirement for the V ␤ 4 + CD8 + T cell response
Although transcription of the M1 ORF occurs during both lytic and latent MHV68 infection, in B cells as well as non-B cells, the ability of MHV68 to establish latency in B cells is the known viral superantigens mediate bridging interactions between MHC class II molecules and V ␤ segments of the TCR ␤ -chain on CD4 + T cells ( 55, 56 ) . In the case of M1, both its specifi city for CD8 + cells and its apparent independence of MHC class Ia interactions are intriguing features that require further elucidation. Importantly, a recent study demonstrated that bacterial superantigens are capable of TCR stimulation independent of lck-mediated phosphorylation events associated with T cell coreceptor engagement ( 57 ) . If conventional superantigen activity functions independent of MHC-specifi city imparted by CD4 and/or CD8 coreceptors, a novel superantigen might circumvent classical MHC -TCR interactions entirely. Indeed, the cumulative data on V ␤ 4 + CD8 + T cell activation support this idea. We confi rmed reports that V ␤ 4 + CD8 + T cell activation occurs in mice lacking ␤ 2m-dependent class I MHC expression (unpublished data), and V ␤ 4 + CD8 + T cell hybridoma activation in the presence of MHC class I and II neutralizing antibodies also argues against a critical role for antigen-presenting molecules in the MHV68-induced response ( 37, 41 ) . The defective V ␤ 4 + CD8 + T cell response in MHV68-infected MHC class II -defi cient mice is likely caused by the absence of CD4 + T cells -a known requirement for V ␤ 4 + CD8 + T cell expansion in vivo ( 32, 36, 58 ) . Therefore, M1 may signal through an interaction with a nonclassical MHC class Ib molecule, or perhaps mediate some novel manipulation of TCR and CD8 ligation that is entirely MHC independent. Further study of the molecular interactions involved in M1-mediated TCR activation will shed light on such possibilities. V ␤ 4 + CD8 + T cell -mediated control of infection M1-mediated stimulation of V ␤ 4 + CD8 + T cells promotes their continual proliferation, potent eff ector cytokine production, and long-term capacity to suppress viral reactivation apparently through IFN ␥ production. These fi ndings support a less appreciated role for noncytolytic CD8 + T cell function mediated by eff ector cytokines. The mechanism by which IFN ␥ controls reactivation is not fully characterized, but even short-course IFN ␥ blockade in vivo results in a greatly increased frequency of MHV68 reactivation from PECs after explant ( 7 ) . Likewise, the increased frequency of PECs that reactivate in culture after an M1-null virus infection is likely the result of the relatively poor IFN ␥ response elicited in the absence of V ␤ 4 + CD8 + T cell expansion. Obviously, the potential sources of IFN ␥ during infection are not limited to V ␤ 4 + CD8 + T cells. Indeed, the frequency of reactivation in the absence of M1 is less exaggerated than that of WT virus in mice lacking IFN ␥ or its receptor ( 59 ) . CD4 + T cells regulate MHV68 infection in an IFN ␥ -dependent manner, whereas NK cells, although likely candidates, do not appear to regulate MHV68 infection ( 60 -62 ) .
Stimulation by M1 does not appear to promote anti-MHV68 cytolytic activity from V ␤ 4 + CD8 + T cells in vivo, because the frequency of latently infected cells does not decrease in their presence. Blackman et al. reported that V ␤ 4 + CD8 + T cells kill targeted cells in a peptide-nonspecifi c manner, that occurs via M1 stimulation. We propose that V ␤ 4 + CD8 + T cells might exhibit aberrant cytolytic activity and bystander killing precisely because reactivating cells fail to respond to IFN ␥ , as diagramed in Fig. 7 . Elucidating a role for M1 in T cell activation will aid further attempts to understand the dynamic at work in this process.
Is there any evidence for superantigen function during human gammaherpesvirus infection or disease? EBV infection induces expression of a human endogenous retroviral superantigen (HERV-K18) encoded by the host cell ( 69 ) . The signifi cance of such superantigen activation on EBV pathogenesis is unclear ( 70, 71 ) . T cell activation after EBV infection is signifi cantly altered during IM, particularly in patients with a genetic defi ciency of the lymphocyte signaling regulator SLAM-associated protein (SAP or SH2D1A ) ( 72 ) . These individuals develop a fatal syndrome known as Xlinked lymphoproliferative disease, presumably as a result of failure to properly regulate antiviral immune responses. This syndrome has been modeled using chronic viral infection of SAP-defi cient mice ( 73 ) . Because the V ␤ 4 + CD8 + T cell response has been proposed as a model for IM, it should be noted that the extent of V ␤ 4 + proliferation after MHV68 infection of SAP-defi cient mice is immensely exaggerated (80 -90% of all CD8 + T cells in circulation are V ␤ 4 + in some animals), and like their human counterparts, these mice develop an immune-mediated pathology in multiple organs ( 74, 75 ) . This raises the question of whether, in both human and murine gammaherpesvirus infection, superantigen-like activity is involved in promoting infl ammatory disease. Further studies of these and other pathologies may identify new roles for microbial immunomodulatory molecules in presumptively autoimmune or chronic infl ammatory processes.
MATERIALS AND METHODS
Viruses and tissue culture. Viral stocks were generated by transfecting WT and mutant MHV68, cloned as a bacterial artifi cial chromosome (BAC), into Vero-Cre cells to excise BAC sequence by Cre-mediated recombination ( 76, 77 ) . NIH 3T12 cells and mouse embryonic fi broblasts (MEFs) were maintained in Dulbecco ' s modifi ed Eagle ' s medium, supplemented with 10% FCS, 100 U of penicillin per ml, 100 mg of streptomycin per ml, and 2 mM l-glutamine (CMEM). MEFs were obtained from C57BL/6 mouse embryos as previously described ( 78 ) . Vero-Cre cells were a gift from D. Leib (Washington University, St. Louis, MO), and they were passaged in CMEM supplemented with 300 1 μ g/ml g/ml Hygromycin B.
Mice and infections. C57BL/6, BALB/c, and IFN ␥ R Ϫ / Ϫ mice (B6.129S7-Ifngr tm1Agt /J) were purchased from The Jackson Laboratory and bred in Emory University ' s animal facilities. Intranasal and intraperitoneal inoculations were performed in a total volume of 20 μ l and 400 μ l, respectively, diluted in CMEM accordingly. Mice were used between 8 -14 wk of age and placed under isofl urane anesthesia before infection and sacrifi ce by cervical dislocation. All protocols for animal studies were approved by the Institutional Animal Use and Care Committee of Emory University.
Histopathology and immunohistochemical slide preparation. Organs were harvested and fi xed overnight in 10% buff ered formalin. 7-μ m sections from paraffi n-embedded tissues were cut and stained with hematoxylin and eosin by the Veterinary Pathology offi ce at Emory University. Images were acquired with an AXIO Imager.A1 microscope and an Axiocam MRc5 (Carl Zeiss, Inc.).
critically important for V ␤ 4 + CD8 + T cell activation ( 30, 36 -38, 64, 65 ) . The strict requirement for M1 expression and B cell latency in the V ␤ 4 + CD8 + T cell response could be explained by several scenarios. The M1 ORF may be diff erentially regulated by alternative promoter usage during B cell infection, similar to the manner in which EBV modulates diff erent latent transcriptional programs ( 66 ) . Alternatively, naive V ␤ 4 + CD8 + T cells may require M1-expressing cells to reside within a specifi c microenvironment or lymphoid tissue during primary stimulation, as is true for antigen-bearing cells during conventional T cell stimulation. Migration of infected B cells might be required in this latter scenario. Regardless, M1 provides a unique T cell -dependent mechanism to elicit host cytokine expression and subsequently inhibit virus reactivation from non-B cell reservoirs that may be less amenable to long term maintenance of the latent viral genome.
In addition, such an extraordinary T cell response could explain several interesting immunological features of MHV68 latency, such as why: (a) B cell -defi cient mice fail to regulate persistent reactivation, but when reconstituted with B cells that do not recognize viral antigen control is recovered in a T cell -dependent manner ( 64, 67 ) ; (b) CD8 + T cells are capable of controlling virus reactivation even in the absence of classical MHC class Ia molecules ( 41 ); (c) MHV68 infection results in enhanced lymphoproliferative disease in the absence of M1 in some settings ( 68 ) ; and (d) M1 is required for MHV68 to promote CD8 + T cell -mediated transplant rejection in latently infected recipients (unpublished data). The possibility that the V ␤ 4 + CD8 + T cell population is playing a role in each of these phenomena is consistent with the available data, and we suggest that this long underappreciated T cell response could aff ect several of these interesting features of MHV68 latency.
Herpesviruses and immune dysfunction MHV68-associated fi brosis and vasculitis are proposed as models of several poorly understood clinical pathologies, implicating latent or unknown herpesviruses in the pathogenesis of human disease. Although these MHV68-induced pathologies do not have perfect clinical correlates to known human gammaherpesvirus-associated diseases, they do provide proof that dysregulated immune function during persistent infection can produce devastating disease, the type that could be misinterpreted as purely autoimmune or idiopathic phenomenon if infection goes undetected. Fibrosis associated with MHV68 requires persistent viral replication ( 11, 15 ), but we show that persistence is insuffi cient in the absence of M1 expression and an activated V ␤ 4 + CD8 + T cell response. The relationship between persistent infection, T cells, and other cell types implicated in MHV68-induced fi brosis (such as macrophages) presents a complex dynamic that will require careful dissection ( 10 ) . Pathological changes in V ␤ 4 + CD8 + T cell activity could result from their own lack of IFN ␥ responsiveness. Alternatively, the chronic infl ammatory environment in persistently infected IFN ␥ R Ϫ / Ϫ mice may enhance V ␤ 4 + CD8 + T cell activation, above and beyond the " priming " Generating recombinant M1.STOP virus. WT MHV68 BAC DNA was mutagenized by allelic exchange in Rec-A -positive Escherichia coli , as previously described ( 76 ) , with the following modifi cations. A DNA fragment containing an M1 kanamycin insertion (M1.Kan) was generated by incorporating a novel Avr II restriction site into position 2153 (GenBank accession no. NC_001826 ) of the M1 ORF with overlap extension PCR. The kanamycin resistance cassette from the Xbal fragment of pCP15 into this site was then subcloned into the AvrII site. The resulting M1.Kan construct was transfered into the pGS284 suicide vector and allelic exchange was performed with the WT MHV68 BAC to generate a kanamycin-resistant BAC in which antibiotic resistance was linked to the M1 ORF (M1.Kan BAC). The M1.STOP mutation, as shown in Fig. 2 C , was also cloned by overlap extension PCR, incorporating two translational termination codons, a single base pair downstream frameshift, and a novel Acl I site into coordinates 2363 through 2373. After sequence confi rmation, the M1.STOP allele was cloned into pGS284, allowing allelic exchange to be performed with M1.Kan BAC to exchange the discrete stop mutation for the Kan insertion. M1.STOP BAC was identifi ed by replica plating for the loss of kanamycin resistance, and the entire region was sequenced to confi rm fi delity. Genomic integrity of all recombinant BACs was confi rmed by Southern blot (Fig. S5 , available at http://www.jem.org/cgi/content/full/jem.20071135/DC1). M1.STOP viral stocks were generated as described.
Protein expression and detection. M1 coding sequence (genomic coordinates 2023 -3285) was PCR amplifi ed from MHV68 BAC DNA, incorporating a BamHI restriction site and a Kozac sequence immediately upstream of the translational start site and a XhoI restriction site immediately downstream of the last codon. Primer sequences were the following: 5 Ј -TCGAACG-GATCCGCCGCCATGCAGCTGGCCACCTTATG-3 Ј and 5 Ј -GGTT-GCCTCGAGGGACTGCTGCCCAGGAAAAAT-3 Ј . PCR products were cloned in-frame with the C-terminal FLAG epitope using the BamHI and XhoI sites contained in the pCMV-Tag4B mammalian expression vector (Stratagene) and sequenced for fi delity. The M3 expression vector was generated in an identical manner, using primer sequences that correspond to genomic coordinates 6060 -7277. The v-cyclin expression vector was generated by cloning sequence corresponding to genomic coordinates 102,423 -103,181 into pCMV-Tag2B (Stratagene).
Expression vectors were transfected into Cos-1 cells using TransIT-LT1 Reagent (Mirus), per the manufacturer ' s instructions. After 48 h, transfected cell supernatants were removed and immunoprecipitated overnight using 30 μ l anti-FLAG M2-agarose affi nity gel (Sigma-Aldrich). Whole-cell lysates were prepared by the addition of E1A lysis buff er (50 mM Hepes, pH 7.2, 250 mM NaCl, 2 mM EDTA, and 0.1% NP-40). Cell lysates and immunoprecipitates were denatured and separated by 10% SDS-PAGE and transferred to nitrocellulose membrane. Nitrocellulose was blocked for 1 h at room temperature, immunoblotted overnight at 4 ° C with anti-FLAG M2-peroxidaseconjugated antibody (Sigma-Aldrich), and antibody was detected using ECL Western Blot Analysis System (GE Healthcare).
Hybridoma stimulation. V ␤ 4 + CD8 + hybridomas (4BH62 and 4BH98) were gifts from M. Blackman (Trudeau Institute, Saranac lake, NY), and the polyoma-specifi c V ␤ 4-CD8 + T cell hybridoma (LT359) was supplied by A. Lukacher (Emory University, Atlanta, GA). Notably, each line was generated from the fusion of mouse splenocytes with the same hybridoma fusion partner, BWZ.36/CD8 ␣ ( 37 ). V ␤ 4 + lines were maintained in Eagle ' s minimum essential media supplemented with 8.5% FCS and 7.25% tumor cocktail (Eagle ' s minimum essential media with 75 ml of 10 × essential aa, 140 ml of 100 × nonessential aa, 100 mM sodium pyruvate, 2 mM l-glutamine, and 7.5 g dextrose/liter, and then pH adjusted to 7.0 with sodium hydroxide before addition of 8.5 g sodium bicarbonate, 500 mg gentamycin, 600 mg penicillin, 1 g streptomycin, and 34 μ l of 2-␤ -mercaptoethanol [ ␤ ME] per liter). LT359 was maintained in CMEM supplemented with sodium pyruvate, nonessential aa, and ␤ ME at the same concentrations indicated in the aforementioned tumor cocktail. During stimulation, 10 5 hybridoma cells were cultured for 24 -36 h in fl at-bottom, 96-well plates, in the presence of Immunohistochemistry was performed on fresh frozen lung sections. Mounted serial sections were blocked before staining for V ␤ 4 TCR and CD8 ␤ (both rat anti -mouse; AbD Serotec) or normal rat IgG (Santa Cruz Biotechnology) as a negative control. Secondary biotinylated rabbit anti -rat (Dako) was used before quenching endogenous peroxidase activity with 0.3% H 2 O 2 and exposure to a streptavidin/horseradish peroxidase conjugate and diaminobenzidine (Vector Laboratories) as chromogen. Various fl uorophore conjugates for each monoclonal species were used in diff erent panels depending on the availability of each conjugated activation marker. For BrdU analysis, mice were given fresh BrdU daily in their drinking water (0.8 mg/ml) for 8 d starting 4 mo after infection. Intracellular staining used a BrdU fl ow kit (BD Biosciences) and followed the manufacturer ' s instructions. Stimulation of cytokine production entailed culturing splenocytes for 4 -6 h in the presence of a 1:100 -1:1,000 dilution of GolgiPlug (BD Biosciences) in fresh CMEM with or without the addition of either 1 μ g/ml of anti-CD3 monoclonal (145-2C11; BD Biosciences). The stimulatory activity of each recombinant protein was assessed by the addition of GolgiPlug alone to the supernatant from Cos-1 cells 48 h after transfection, and then using the supernatant for splenocyte culture. After stimulation, surface staining was performed as above, followed by cell permeabilization and fi xation (Cytofi x/Cytoperm kit; BD Biosciences) and intracellular staining for V ␤ 4 TCR (required because of surface downmodulation during stimulation), IFN ␥ (XMG1.2), and TNF-␣ . Data were collected on a FACSCalibur (BD Biosciences) and analyzed using FlowJo software (Tree Star, Inc.).
Plaque assays. Plaque assays were performed as previously described ( 18 ) , with the following alterations. Tissues were weighed before freezing in 1 ml CMEM, and then thawed and homogenized by mechanical disruption with 1.0 mm zirconia/silica beads in a Mini-Beadbeater 8 (Biospec Products). 10-fold dilutions made in CMEM were plated onto monolayers of 2 × 10 5 NIH 3T12 fi broblasts. Samples were overlaid with 5 ml of 2% methylcellulose in CMEM, and after 7 d, plaques were counted by microscopic examination. Plaque titers were normalized per gram of tissue, and the limit of detection for this assay is based on detection of 5 PFU per 0.1 g of tissue.
Limiting dilution ex vivo reactivation assay. Detection of MHV68 reactivation from latency was performed as previously described ( 67 ) . In brief, cells were plated in a series of twofold dilutions, starting at 10 5 cells per well, onto MEF monolayers in 96-well tissue culture plates. After 21 d, wells were scored microscopically for the presence of CPE. To detect preformed infectious virus, parallel samples were subjected to mechanical disruption as previously described, killing > 99% of cells. Disrupted cells were plated in a similar series of twofold dilutions.
Limiting dilution nested PCR detection of MHV68 genome-positive cells. We determined the frequency of cells containing MHV68 genome using a previously described nested PCR assay (LD-PCR) with approximately single-copy sensitivity to detect gene 50 of MHV68 ( 67 ) . In brief, cells were counted and resuspended in an isotonic solution, and diluted in a background of 10 4 uninfected NIH 3T12 cells. After overnight lysis of cells with proteinase K, two rounds of nested PCR were performed on each sample. Products were analyzed by ethidium bromide staining of a 2% agarose gel. To quantitate PCR sensitivity, 10, 1, or 0.1 copies of a gene 50 containing plasmid (p Bam H I N) were diluted into a background of 10 4 uninfected cells.
